主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNSP
#4006
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
版块:
基础:
利润货币:
日范围
年范围
日变化
+4.29%
每月变动
-48.11%
6个月变化
-49.76%
年变化
+35.62%
前一天收盘价
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
交易量
4
市场
股票
医疗保健
CNSP
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
-1.6
-1.17
-11.08
-1.71
-1.11
Return on equity %
0.68
-2.12
-1.88
4.25
-2.41
-1.41
Return on invested capital %
6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
—
Gross margin %
100
—
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
24.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0
0
Solvency ratios
Debt to assets ratio
0.06
0.09
0.07
—
—
—
Debt to equity ratio
0.07
0.12
0.11
—
—
—
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.08
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-204.35
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
18.94 K
—
—
—
Cash per share
—
—
221.53 K
4 369.53
202.85
310.69
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
390.8
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Working capital per share
—
—
168.41 K
-36.17 K
192.58
292.07
Book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
新闻
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security公布DDoS防护平台增强功能
Corero Network Security reports DDoS protection platform enhancements
CNS制药公司股价下跌,CEO辞职
CNS Pharmaceuticals stock falls after CEO steps down
CNS制药任命Rami Levin为CEO,John Climaco辞职
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS制药公司股东在年度会议上批准增加股份并选举董事会成员
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
Corero Network Security报告第三季度订单增长